A CRISPR-based gene editing therapy dramatically reduced levels of low-density lipoprotein, often called “bad cholesterol,” and triglycerides in patients with heart disease, a new study found.

Gene editing to change low density lipoprotein = wrong technique, wrong target

The correct technique is breeding for the desired result.

The correct target could be longer lifespan — up to 200 years, or higher intelligence up to 157 IQ, or better earnings skills (like Bezos or Musk).

Gene editing is risky and unlikely to work.

Better breeding is very low risk and highly likely to work.

See my books on Amazon.com

1822 Relevant Genes from One Man, Can Be Matched Up with Those Same 1822 Relevant Genes from One Woman, Who Is a Prospective (Possible) Mate for Said Man.